ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today ...

ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...

International companies are increasingly inking licensing deals with China biotechs as concerns regarding drug pricing and ...

Sun recieved approval from the US Food and Drug Administration for Leqselvi in July 2024. Soon after the regulator’s approval ...

Plaintiffs allege that CRISP and its subsidiary willfully infringed on patented technology by launching a copycat product after terminating a long-standing licensing agreement.

After resolving a patent dispute with Incyte, Sun Pharma has officially launched its JAK inhibitor Leqselvi in the U.S. | Sun ...

China-based biotech CARsgen Therapeutics (HKEX: 2171) has strengthened its grip on intellectual property in the CAR-T space ...

The Inner House of the Court of Session has refused a reclaiming motion against a decision that the licensee of several patents owned by a UK company was liable to pay royalties until the end of the ...

The VDP Pool from AccessAdvance has successfully attracted a group of licensees/licensors including ByteDance, Kuaishou, NTT ...

How can countries foster pharmaceutical innovation without making life-saving medicines inaccessible? India’s experience offers a compelling answer and in 2025, the country will mark 20 years since it ...

When blockbuster drugs lose intellectual property protections it can wipe out billions of dollars in revenue for companies ...

Players of Fortnite are also directly infringing on a patent by using the game’s communication system, an obscure patent ...